gip/glp-1 receptor agonist New strategies for the treatment of obesity and metabolic dysfunctions Mechanisms of action and therapeutic
Description
Tapering protocols that reduce the shock of discontinuation
Middle East & Africa Fire Safety Systems & Equipment Market Click here to view more
SID-AMD joint panel for Italian Guidelines on Treatment of Type 2 Diabetes Cardiovascular Events and All-Cause Mortality in Patients with Type 2 Diabetes Treated with Dipeptidyl Peptidase-4 Inhibitors: An Extensive Meta-Analysis of Randomized Controlled Trials
& Derkinderen, P
GLP-1 Receptor Agonists in the Treatment of Polycystic Ovary Syndrome
Glucagon-like Peptide-1 Receptor Agonists and the Risk of Acute Kidney Injury: Alarming, or Not
